نتائج البحث - "Meier, Juris J."

1

دورية أكاديمية

Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes.

المؤلفون: Aroda, Vanita R., Erhan, Umut, Jelnes, Peter, Meier, Juris J., Abildlund, Morten Tind, Pratley, Richard, Vilsbøll, Tina, Husain, Mansoor

المصدر: Diabetes, Obesity & Metabolism; May2023, Vol. 25 Issue 5, p1385-1397, 13p

مصطلحات موضوعية: SEMAGLUTIDE, GLUCAGON-like peptide-1 receptor, MAJOR adverse cardiovascular events, ARRHYTHMIA, GLUCAGON-like peptide-1 agonists, CLINICAL trials

2

دورية أكاديمية

Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results.

المؤلفون: Guja, Cristian, Giorgino, Francesco, Blonde, Lawrence, Ali, Amar, Prázný, Martin, Meier, Juris J., Souhami, Elisabeth, Lubwama, Robert, Ji, Chen, Rosenstock, Julio

المصدر: Diabetes Therapy; Jan2022, Vol. 13 Issue 1, p205-215, 11p

مصطلحات موضوعية: GLUCAGON-like peptide-1 agonists, TYPE 2 diabetes, DISEASE risk factors, GLUCAGON-like peptide-1 receptor, GLYCEMIC control, MEDICAL record databases

النص الكامل

3

دورية أكاديمية

Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short‐ and long‐acting glucagon‐like peptide‐1 receptor agonists in type 2 diabetes.

المؤلفون: Quast, Daniel R., Nauck, Michael A., Schenker, Nina, Menge, Björn A., Kapitza, Christoph, Meier, Juris J.

المصدر: Diabetes, Obesity & Metabolism; Oct2021, Vol. 23 Issue 10, p2344-2353, 10p

مصطلحات موضوعية: GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide-1 agonists, APPETITE, TYPE 2 diabetes, FOOD preferences, PEPTIDE receptors, PANCREAS, ELASTASES

4

دورية أكاديمية

Efficacy of Semaglutide in a Subcutaneous and an Oral Formulation.

المؤلفون: Meier, Juris J.

المصدر: Frontiers in Endocrinology; 6/25/2021, Vol. 12, p1-11, 11p

مصطلحات موضوعية: TYPE 2 diabetes, SEMAGLUTIDE, GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide-1 agonists, GLYCOSYLATED hemoglobin, CANAGLIFLOZIN

النص الكامل

5

دورية أكاديمية

Efficacy and Safety of Short- and Long-Acting Glucagon-Like Peptide 1 Receptor Agonists on a Background of Basal Insulin in Type 2 Diabetes: A Meta-analysis.

المؤلفون: Huthmacher, Jessica A.¹, Meier, Juris J.¹, Nauck, Michael A.¹ michael.nauck@rub.de

المصدر: Diabetes Care. Sep2020, Vol. 43 Issue 9, p2303-2312. 10p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 agonists, *GLUCAGON-like peptide 1, *PEPTIDE receptors, *TYPE 2 diabetes, *BLOOD sugar, *INSULIN, *ONLINE information services, *META-analysis, *SYSTEMATIC reviews, *HYPOGLYCEMIC agents, *MEDLINE

النص الكامل

6

دورية أكاديمية

Effects of Lixisenatide Versus Liraglutide (Short- and Long-Acting GLP-1 Receptor Agonists) on Esophageal and Gastric Function in Patients With Type 2 Diabetes.

المؤلفون: Quast, Daniel R., Schenker, Nina, Menge, Björn A., Nauck, Michael A., Kapitza, Christoph, Meier, Juris J.

المصدر: Diabetes Care; Sep2020, Vol. 43 Issue 9, p2137-2145, 9p

مصطلحات موضوعية: GLUCAGON-like peptide-1 agonists, TYPE 2 diabetes, GLUCAGON-like peptide 1, ESOPHAGEAL motility, ESOPHAGOGASTRIC junction, GASTRIC acid, ESOPHAGUS, GASTROINTESTINAL motility, RESEARCH, RESEARCH methodology, HYPOGLYCEMIC agents, MEDICAL cooperation, EVALUATION research, GASTROESOPHAGEAL reflux, COMPARATIVE studies, RANDOMIZED controlled trials, PEPTIDES, PHARMACODYNAMICS

النص الكامل

7

دورية أكاديمية

Efficacy, safety and cardiovascular outcomes of once‐daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme.

المؤلفون: Thethi, Tina K., Pratley, Richard, Meier, Juris J.

المصدر: Diabetes, Obesity & Metabolism; Aug2020, Vol. 22 Issue 8, p1263-1277, 15p

مصطلحات موضوعية: TYPE 2 diabetes, GLUCAGON-like peptide-1 receptor, BLOOD sugar, GLUCAGON-like peptide-1 agonists, GLYCEMIC control, GLUCOSE-regulated proteins, SODIUM-glucose cotransporters

الشركة/الكيان: PIONEER Corp.

8

دورية أكاديمية

Incretin‐based glucose‐lowering medications and the risk of acute pancreatitis and malignancies: a meta‐analysis based on cardiovascular outcomes trials.

المؤلفون: Abd El Aziz, Mirna, Cahyadi, Oscar, Meier, Juris J., Schmidt, Wolfgang E., Nauck, Michael A.

المصدر: Diabetes, Obesity & Metabolism; Apr2020, Vol. 22 Issue 4, p699-704, 6p

مصطلحات موضوعية: GLUCAGON-like peptide-1 agonists, PANCREATITIS, META-analysis, DRUGS, PANCREATIC cancer

9

دورية أكاديمية

Are all GLP-1 agonists equal in the treatment of type 2 diabetes?

المؤلفون: Nauck, Michael A.¹ michael.nauck@rub.de, Meier, Juris J.¹

المصدر: European Journal of Endocrinology. Dec2019, Vol. 181 Issue 6, pR211-R234. 24p.

مصطلحات موضوعية: *GLUCAGON-like peptide-1 agonists, *TYPE 2 diabetes, *CARDIOVASCULAR diseases risk factors, *REGULATION of body weight, *CONGESTIVE heart failure

النص الكامل

10

دورية أكاديمية

Incretin hormones: Their role in health and disease.

المؤلفون: Nauck, Michael A.¹ michael.nauck@rub.de, Meier, Juris J.¹

المصدر: Diabetes, Obesity & Metabolism. Feb2018 Supplement S1, Vol. 20, p5-21. 17p.

مصطلحات موضوعية: *INCRETINS, *GASTRIC inhibitory polypeptide, *GLUCAGON-like peptide-1 agonists, *GLYCEMIC control, *CARDIOVASCULAR disease prevention, *PATHOLOGICAL physiology, *TYPE 2 diabetes

تنقيح النتائج